```json
{
"content": [
{
"type": "list",
"title": "Growth Drivers",
"items": [
{
"text": "Rising prevalence of traumatic brain injuries and stroke is accelerating demand for real-time, non-invasive cerebral edema monitoring solutions, with market size expected to reflect this surge in key regions.",
"level": 1
},
{
"text": "Advancements in near-infrared spectroscopy (NIRS) and optical coherence tomography (OCT) are enhancing device accuracy, enabling broader adoption in ICU settings and driving growth forecast optimism.",
"level": 1
}
]
},
{
"type": "list",
"title": "Restraints",
"items": [
{
"text": "High upfront costs compared to traditional invasive monitors limit accessibility in budget-constrained healthcare systems, particularly in emerging economies.",
"level": 1
},
{
"text": "Stringent regulatory requirements for approval in markets like the EU and Japan delay product commercialization, slowing market expansion timelines.",
"level": 1
}
]
},
{
"type": "list",
"title": "Opportunities",
"items": [
{
"text": "Growing telemedicine adoption creates opportunities for cloud-integrated non-invasive cerebral edema monitors, enabling remote patient monitoring and expanding market reach.",
"level": 1
},
{
"text": "Partnerships with academic institutions for clinical validation studies can accelerate adoption in hospitals, leveraging data-driven evidence to overcome skepticism about accuracy.",
"level": 1
}
]
},
{
"type": "list",
"title": "Challenges",
"items": [
{
"text": "Reimbursement limitations for non-invasive monitoring technologies hinder widespread adoption, despite their long-term cost-saving potential.",
"level": 1
},
{
"text": "Competition from established invasive monitoring systems, which remain the standard of care in many hospitals due to entrenched clinical workflows.",
"level": 1
}
]
}
]
}
```
